UnitedHealth squeezes 75.0% more profit out of the same USD 113bn

The till stood still, the bottom line did not

Most Americans with health insurance through an employer, Medicare or Medicaid have met UnitedHealth Group somewhere: on an insurance card from UnitedHealthcare, at a clinic or pharmacy run by its Optum arm, or on a claim it processed. It is one of the largest healthcare companies in the world, and its accounts are consolidated under US GAAP, in US dollars, for the whole group.

In the third quarter of 2026, from July to September, the group took in USD 113bn in revenue. A year earlier the figure was USD 113bn. The difference is USD 467m, a dip of 0.4%. In a company this size, that is a rounding error on the scale of a mid-sized hospital.

Profit tells another story. Operating profit, what is left after running the business and paying for care, rose from USD 4.3bn to USD 6.6bn, an increase of 52.1%. Net profit, after interest and tax, climbed from USD 2.3bn to USD 4.1bn, up 75.0%.

So the same flow of premiums and fees left far more behind for the owners. The question worth answering is how a quarter with no growth at the top turned into one of strong growth at the bottom.

Why a thin margin moves so much

A health insurer is, in plain terms, a pass-through machine. Employers, individuals and the government pay premiums. Most of that money goes straight back out as payments to doctors, hospitals and pharmacies. What the company keeps is a small slice in between.

That slice is visible in the operating margin, the share of each revenue dollar left as operating profit. In the third quarter of 2025 it stood at 3.8%. A year later it was 5.8%, a widening of 2.0 pp. That sounds modest. On a revenue base of USD 113bn, it is the whole difference between the two quarters.

This is the arithmetic of thin margins. When almost all of the revenue is spent again, a small change in the spending moves profit a long way. If care costs per member come in slightly below what the premiums were priced for, the saving falls almost entirely to profit. If they come in slightly above, the opposite happens, and it happens just as fast.

Revenue was flat, so the improvement did not come from selling more. It came from the cost side. There are several ordinary ways that can happen at an insurer: premiums repriced to catch up with higher medical bills, members using fewer costly treatments, a change in the mix of plans, or a weak base quarter that contained unusual charges. The headline figures do not say which of these did the work. The number that would settle it is the medical cost ratio, the share of premiums paid out as care, and that is the line I would watch in the next quarter.

One thing the figures do rule out is a change in how the business is depreciated. Depreciation and amortisation, the accounting cost of buildings, equipment, software and acquired businesses, was USD 1.1bn a year ago and USD 1.1bn now. That is why EBITDA, operating profit with depreciation added back, rose by USD 2.2bn, the same dollar amount as operating profit, and its margin widened by 2.0 pp. The gain sits in the operations themselves, not in the accounting below them.

Net profit grew faster than operating profit, 75.0% against 52.1%, and the net margin widened from 2.1% to 3.6%. The lines between the two, mainly interest and income tax, therefore took a smaller share of the profit than a year earlier. The accounts do not break that gap down by item here, so I would not build a theory on it.

A stronger quarter does not mean a richer balance sheet yet

The balance sheet moved much less than the income statement. Total assets stood at USD 313bn at the end of September 2026, against USD 315bn a year earlier. Equity, the owners' stake in the group, rose from USD 102bn to USD 104bn, an increase of 2.5%. The equity ratio, the share of assets financed by the owners rather than by creditors, edged up from 32.2% to 33.3%.

Cash went the other way. It fell from USD 27.2bn to USD 25.8bn, down 5.0%. That is not a contradiction. Cash at the end of a quarter is a snapshot, and a group like this one pays dividends, buys back shares, repays debt and buys businesses from the same pile. A better quarter of profit shows up in the cash balance only after all those uses have taken their share.

What it means for patients, employers and anyone running on thin margins

For the people who pay premiums, the pattern is the part to understand. A profit jump at a health insurer, on flat revenue, means the gap between what was charged and what care cost has widened again. Whether that came from higher prices or lower use of care makes a real difference to employers negotiating next year's plans, and to the government agencies that pay for Medicare and Medicaid members. The same lever that lifted this quarter can turn against the company the moment medical bills rise faster than premiums can be repriced, and in health insurance prices are usually set a year ahead.

For the market, UnitedHealth is a bellwether. When the largest player keeps more of each dollar, it tells you something about how medical costs and pricing are lining up across the industry, though a single quarter against a single quarter is a thin base for a trend.

For anyone running a business with thin margins, such as a wholesaler, a staffing agency or a contractor, the takeaway fits in a spreadsheet. Take your largest cost line and work out how much operating profit would change if it moved by a small fraction of revenue in either direction. If the answer is most of your profit, you are running the same machine as UnitedHealth, only without the actuaries.

UnitedHealth did not grow in the third quarter of 2026. It got better at keeping what passed through its hands, and in a business with margins this thin, that is the only lever that really matters. The next quarter will show whether the lever stays pulled.